Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: Results from two randomized, proof-of-concept studies

British Journal of Dermatology

Volumn 158, Issue 1, 2008, Pages 109-115

  Gassmueller, J ^a   Hoffmann, R ^b   Webster, A ^c  

^a Bioskin Institute for Dermatological Research and Development GmbH   (Germany)

^b Tricholog GmbH   (Germany)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Androgenetic alopecia; Fulvestrant; Randomized controlled trial; Topical; Treatment; TrichoScan

Indexed keywords

FULVESTRANT; MINOXIDIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GROWTH RATE; HAIR GROWTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ALOPECIA; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HAIR; HUMANS; MALE; MIDDLE AGED; MINOXIDIL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 36849053335     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08276.x     Document Type: Article

References (31)

1. Sinclair R. Male pattern androgenetic alopecia. BMJ 1998 317 : 865 9.
2. Thiedke CC. Alopecia in women. Am Fam Physician 2003 67 : 1007 14.
3. Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005 331 : 951 3.
4. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004 150 : 186 94.
5. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999 341 : 491 7.
6. The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002 12 : 38 49.
7. Whitaker WL, Baker BL. A comparison of the direct action of estrogen and adrenal cortical extracts on growth of hair in the rat. J Invest Dermatol 1951 17 : 69 77.
8. Ingle DJ, Baker BL. The inhibition of hair growth by estrogens as related to adrenal cortical function in the male rat. Endocrinology 1951 48 : 764 71.
9. Baker BL, Whitaker WL. Relationship of the adrenal cortex to inhibition of growth of hair by estrogen. Am J Physiol 1949 159 : 118 23.
10. Trentin JJ, Devita J, Gardner WU. Effect of moderate doses of estrogen and progesterone on mammary growth and hair growth in dogs. Anat Rec 1952 113 : 163 77.
11. Kostanecki W, Bosse K, Krempl-Lamprecht L. The effect of 16-epiestriol on the skin cycle in mice. Arch Klin Exp Dermatol 1963 217 : 480 8.
12. Hale PA, Ebling FJ. The effects of epilation and hormones on the activity of rat hair follicles. J Exp Zool 1975 191 : 49 62.
13. Jackson D, Ebling FJ. The activity of hair follicles and their response to oestradiol in the guinea-pig Cavia porcellus L. J Anat 1972 111 : 303 16.
14. Oh HS, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 1996 93 : 12525 30.
15. Chanda S, Robinette CL, Couse JF et al. 17beta-estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-alpha pathway. Am J Physiol Endocrinol Metab 2000 278 : E202 10.
16. Conrad F, Ohnemus U, Bodo E et al. Substantial sex-dependent differences in the response of human scalp hair follicles to estrogen stimulation in vitro advocate gender-tailored management of female versus male pattern balding. J Investig Dermatol Symp Proc 2005 10 : 243 6.
17. Jaber BM, Gao T, Huang L et al. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-α with the 3′,5′-cyclic adenosine monophosphate response element-binding protein/p300 coactivators. Mol Endocrinol 2006 20 : 2695 710.
18. Moverare S, Lindberg MK, Faergemann J et al. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the hair follicle cycling as well as the thickness of epidermis in male mice. J Invest Dermatol 2002 119 : 1053 8.
19. Smart RC, Oh HS, Chanda S et al. Effects of 17-beta-estradiol and ICI 182 780 on hair growth in various strains of mice. J Investig Dermatol Symp Proc 1999 4 : 285 9.
20. Smart RC, Oh HS. On the effect of estrogen receptor agonists and antagonists on the mouse hair follicle cycle. J Invest Dermatol 1998 111 : 175.
21. Stenn KS, Paus R, Filippi M. Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol 1998 110 : 95.
22. Ohnemus U, Uenalan M, Handjiski B et al. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage. J Invest Dermatol 2004 122 : 7 13.
23. Ohnemus U, Uenalan M, Conrad F et al. Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling. Endocrinology 2005 146 : 1214 25.
24. Thornton MJ, Nelson LD, Taylor AH et al. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta? J Invest Dermatol 2006 126 : 2010 18.
25. Thornton MJ, Taylor AH, Mulligan K et al. The distribution of estrogen receptor β is distinct to that of estrogen receptor α and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp 2003 8 : 100 3.
26. Conrad F, Paus R. Estrogens and the hair follicle. J Dtsch Dermatol Ges 2004 2 : 412 23.
27. Ohnemus U, Uenalan M, Inzunza J et al. The hair follicle as an estrogen target and source. Endocr Rev 2006 27 : 677 706.
28. AstraZeneca. Data on File, 2005.
29. Hoffmann R. TrichoScan: what is new? Dermatology 2005 211 : 54 62.
30. Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998 139 : 4252 63.
31. LaVallee TM, Zhan XH, Herbstritt CJ et al. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 2002 62 : 3691 7.